The Jin Pharmaceutical Group, Conference Room.
Jin Yihong convened a board meeting.
All the top executives were in attendance. The Jin Pharmaceutical Group had been advancing triumphantly as of late, and its stock price had reached a new high.
The board members were all beaming, eagerly anticipating today's meeting.
As expected, once the meeting began, Chairman Jin announced a piece of tremendous good news!
"Our anti-tumor traditional Chinese medicine, the 'Yangzheng Xiujie Pill,' has officially been approved by the National Medical Products Administration. Here are the new drug clinical trial approval, the new drug certificate, and the production license!"
"In other words, our years of hard work are finally coming to fruition."
"Starting today, our new drug can officially enter mass production!"
